SECUKINUMAB
UNII DLG4EML025

Substance Identification & Data

This profile provides standardized clinical and technical data for Secukinumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DLG4EML025.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1229022-83-6 and the RxNorm Concept ID (RxCUI) 1599788. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DLG4EML025

CAS Registry Number

1229022-83-6

RxNorm Concept ID

1599788

Detailed Substance Profile

Preferred Name

SECUKINUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

DLG4EML025

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C152315

National Cancer Institute reference terminology for clinical and research data.

INN ID

9182

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

XX-120

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Secukinumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.